Switch View
© PR Newswire
29.10.2025
ISIN: US1266501006
CVS Health Corp
CVS
LISTED
NYSE
CVS HEALTH CORPORATION REPORTS THIRD QUARTER 2025 RESULTS AND UPDATES FULL-YEAR 2025 GUIDANCE
News Preview
Financial Highlights
Third quarter total revenues increased to a record high $102.9 billion, up 7.8% compared to prior year
Third quarter GAAP diluted loss per share of $3.13, inclusive of a $5.7 billion goodwill impairment charge related to th...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US4525EP1011
Immunic Inc
IMUX
LISTED
NASDAQ
Immunic to Participate in Industry and Investor Conferences in November
News Preview
NEW YORK, Oct. 29, 2025 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following industry and investor conferences in Novemb...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: CA58471K2020
Medicus Pharma Ltd.
MDCX
LISTED
TSX
Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for SKINJECT™ in Patients with Gorlin Syndrome
News Preview
Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000 people worldwide that can develop 500-1000 Basal Cell Carcinoma (BCC) lesions over lifetime Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000 pe...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
29.10.2025
ISIN: CA92767B1058
Vireo Growth Inc
VREO
LISTED
CSE
Vireo Growth Inc. and Verano Holdings Corp. Announce Resolution of Litigation Matters
News Preview
CHICAGO and MINNEAPOLIS, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo”) (CSE: VREO; OTCQX: VREOF) and Verano Holdings Corp. (“Verano”, Vireo and Verano, each a “Company”) (Cboe CA: VRNO) (OTCQX: VRNOF) today announced that they have reached a comprehensive settlement (the “Settlement Agreement”) dismissing all outstanding litigatio...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
29.10.2025
ISIN: US68554V1089
OraSure Technologies Inc
OSUR
LISTED
NASDAQ
OraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5th
News Preview
BETHLEHEM, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering third quarter 2025 financial results and certain business developments for 5 p.m. ET on November 5, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US00461U1051
Aclaris Therapeutics Inc
ACRS
LISTED
NASDAQ
Aclaris Therapeutics to Participate in Three November Healthcare Conferences
News Preview
Aclaris Therapeutics to Participate in Three November Healthcare Conferences...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US0327973006
Anavex Life Sciences Corp
AVXL
LISTED
NASDAQ
Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Control Group
News Preview
ADAS-Cog13 difference −12.78 (P < 0.0001) with oral blarcamesine treatment compared to ADNI control group at Week 144...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US4884452065
Zevra Therapeutics Inc
ZVRA
LISTED
NASDAQ
Zevra Therapeutics to Participate in the Guggenheim Healthcare Innovation Conference
News Preview
CELEBRATION, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that members of Zevra’s executive leadership team will participate in a fireside discussion at Guggenheim's 2nd Annua...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US91307C1027
United Therapeutics Corp
UTHR
LISTED
NASDAQ
United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results
News Preview
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced record financial results for the quarter ended September 30, 2025, driven by continued year-over-year revenue growth in key products such as Tyvaso® and Orenitram®. Total revenues in the third quarter of 2025 grew seven percent year-over-year to $799.5 mi...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US26745T1016
Dyadic International Inc
DYAI
LISTED
NASDAQ
Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025
News Preview
Dyadic to Report Third Quarter 2025 Financial Results on
Wednesday, November 12, 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US36266G1076
GE Healthcare Technologies Inc
GEHC
LISTED
NASDAQ
GE HealthCare reports third quarter 2025 financial results
News Preview
GE HealthCare (Nasdaq: GEHC) today reported financial results for the third quarter ended September 30, 2025.
GE HealthCare President and CEO Peter Arduini said, “We delivered robust orders with growth across all segments in the third quarter. This was led by customer demand for our differentiated solutions and a healthy capital equipment enviro...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Avantor® Reports Third Quarter 2025 Results
News Preview
Net sales of $1.62 billion, decrease of 5%
Net loss of $712 million and diluted GAAP loss per share of $1.04, including a non-cash goodwill impairment charge of $785 million
Adjusted EBITDA of $268 million; adjusted EPS of $0.22
Operating cash flow of $207 mil...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
29.10.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
CENTENE CORPORATION REPORTS THIRD QUARTER 2025 RESULTS
News Preview
-- GAAP Diluted Loss Per Share of $(13.50); Adjusted Diluted Earnings Per Share of $0.50 --
Adjusted diluted EPS of $0.50 in the third quarter of 2025, including a $0.10
benefit of a low adjusted effective tax rate in the...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: KYG8807B1068
Theravance Biopharma Inc
TBPH
LISTED
NASDAQ
Theravance Biopharma to Present Data on Ampreloxetine at the 36th International Symposium on The Autonomic Nervous System
News Preview
Ampreloxetine clinical development program to be featured in four presentations at the upcoming International Symposium on The Autonomic Nervous System
Topline results from the ongoing Phase 3 CYPRESS study of ampreloxetine anticipated in Q1 2026...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: CH1384053976
NLS Pharmaceutics AG
NLSP
LISTED
NASDAQ
NLS Pharmaceutics Ltd. Announces 1-for-10 Reverse Share Split and Name Change in Connection with Proposed Merger with Kadimastem
News Preview
ZURICH, Oct. 29, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, today announc...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Communiqué de presse : Sanofi ancre son futur en France avec un nouveau siège emblématique à Paris La Défense
News Preview
Sanofi ancre son futur en France avec un nouveau siège emblématique à Paris La Défense...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US6876041087
Oruka Therapeutics, Inc.
ORKA
LISTED
NASDAQ
Oruka Therapeutics to Present at Multiple November Investor Conferences
News Preview
MENLO PARK, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis, today announced presentations at the following upcoming investor conferenc...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US30233G2093
EyePoint Pharmaceuticals Inc
EYPT
LISTED
NASDAQ
EyePoint to Report Third Quarter 2025 Financial Results on November 5, 2025
News Preview
WATERTOWN, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced it will host a conference call and live webcast at 8:30 a.m. ET on Wednesday, November 5, 2...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US5147661046
Lifecore Biomedical Inc
LFCR
LISTED
NASDAQ
Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company
News Preview
Lifecore to Execute Commercial Site Transfer and Become New Supplier of Choice for Leading Commercial Injectable Pharmaceutical Product...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US05463X1063
AxoGen Inc
AXGN
LISTED
NASDAQ
Axogen, Inc. Reports Third Quarter 2025 Financial Results
News Preview
Raises Full Year Revenue Guidance to at Least 19% Growth or $222.8 million Raises Full Year Revenue Guidance to at Least 19% Growth or $222.8 million...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US3596161097
Fulcrum Therapeutics Inc
FULC
LISTED
NASDAQ
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2025
News Preview
― Announced encouraging results in July 2025 from the 12 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD) ―...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US8835561023
Thermo Fisher Scientific Inc
TMO
LISTED
NYSE
Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights
News Preview
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a definitive agreement to acquire Clario Holdings, Inc., a leading provider of endpoint data solutions for clinical trials, from a shareholder group led by Astorg and Nordic Capital, Novo Holding and Cinven, for $8.875 billion in cash at close plus pote...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: CA68617J1003
Organigram Global Inc
OGI
LISTED
NASDAQ
Majority of Canadians Want Carney Government to Catch Up on Cannabis Policy
News Preview
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), Canada’s largest cannabis company by market share, today released new national polling figures, conducted on its behalf by Abacus Data showing that a clear majority of Canadians want Ottawa to modernize its approach to the legal cannabis sector.
Nearly six in ten Canadians (59%) believe the federa...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US5019761049
Kyverna Therapeutics, Inc.
KYTX
LISTED
NASDAQ
Kyverna Therapeutics Announces Positive Interim Phase 2 Data from KYSA-6 Study of KYV-101 in Generalized Myasthenia Gravis at AANEM 2025
News Preview
Compelling results set new clinical standard in generalized myasthenia gravis (gMG), increasing confidence in the Company’s registrational KYSA-6 Phase 3 MG trial...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: CA64119M1059
Netramark Holdings Inc
AIAI
LISTED
CSE
NetraMark Presents AI-Driven Advances in Precision Psychiatry to Enhance Clinical Trial Designs at Joint Autumn Conference
News Preview
TORONTO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, presented two significant applications of its technolo...
Themefolio
Profiler
Peergroup
© EQS Newswire
29.10.2025
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Bekanntgabe der Ergebnisse für die ersten neun Monate 2025 am 05. November 2025
News Preview
Hamburg, 29. Oktober 2025:
Evotec SE (Frankfurter Wertpapierbörse: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ: EVO) veröffentlicht am Mittwoch, 05. November 2025, ihre Zwischenmitteilung für die ersten neun Monate 2025.
In einer Telefonkonferenz in englischer Sprache werden die Ergebnisse und Schwerpunkte aus dem Beri......
Themefolio
Profiler
Peergroup
© EQS Newswire
29.10.2025
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec SE to announce results for the first nine months 2025 on 05 November 2025
News Preview
Hamburg, Germany, 29 October 2025:
Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ: EVO) will announce its interim statement for the first nine months 2025 on Wednesday, 05 November 2025.
The Company is going to hold a conference call to discuss the results as well as provide an update ......
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: SE0011205202
Vitrolife AB
VITR
LISTED
STO
Nomination committee of Vitrolife AB (publ) for the Annual General Meeting 2026
News Preview
GOTHENBURG, Sweden, Oct. 29, 2025 /PRNewswire/ -- In accordance with the Nomination Committee Charter adopted at the Annual General Meeting 2025, the members who, together with the Chair of the Board, constitute the Nomination Committee in preparation of the Annual General Meeting 2026 have been elected....
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: CH1384053976
NLS Pharmaceutics AG
NLSP
LISTED
NASDAQ
NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares
News Preview
ZURICH and NESS ZIONA, Israel, Oct. 29, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company") and Kadimastem Ltd. (TASE: KDST) ("Kadimastem") today announced that, following the receipt of Nasdaq's approval for the listing of the Company's common shares and the trading of t...
Themefolio
Profiler
Peergroup
© EQS Newswire
29.10.2025
ISIN: DE0005550602
Draegerwerk AG & Co KGaA
DRW8
LISTED
XETR
Dräger with strong demand, noticeable net sales growth and very good earnings performance in the first nine months of 2025
News Preview
Dräger with strong demand, noticeable net sales growth and very good earnings performance in the first nine months of 2025
Order intake significantly increased
Net sales growth in both divisions and all regions
EBIT up substantially excluding positive one-off effects in the prior year
Considerable increase in net sales and earnings in the third......
Themefolio
Profiler
Peergroup
© EQS Newswire
29.10.2025
ISIN: DE0005550602
Draegerwerk AG & Co KGaA
DRW8
LISTED
XETR
Dräger mit kräftiger Nachfrage, spürbarem Umsatzwachstum und sehr guter Ergebnisentwicklung in den ersten neun Monaten 2025
News Preview
Dräger mit kräftiger Nachfrage, spürbarem Umsatzwachstum und sehr guter Ergebnisentwicklung in den ersten neun Monaten 2025
Auftragseingang deutlich erhöht
Umsatzwachstum in beiden Segmenten und allen Regionen
EBIT ohne Berücksichtigung positiver Einmaleffekte im Vorjahr erheblich gestiegen
Signifikanter Umsatz- und Ergebnissprung im dritten Qu......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.10.2025
ISIN: CA58471K2020
Medicus Pharma Ltd.
MDCX
LISTED
TSX
Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for Skinject(TM) in Patients with Gorlin Syndrome
News Preview
Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000 people worldwide that can develop 500-1000 Basal Cell Carcinoma (BCC) lesions over lifetime PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / October 29, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the &q...
Themefolio
Profiler
Peergroup
© EQS Newswire
29.10.2025
ISIN: CH1175448666
Straumann Holding AG
STMN
LISTED
SIX
Straumann Group erzielt starkes organisches Wachstum und bestätigt den Ausblick für das Gesamtjahr 2025
News Preview
Umsatz im dritten Quartal belief sich auf CHF 602.2 Mio. bei einem starken organischen Wachstum von 8.3%
EMEA blieb wichtigster Wachstumstreiber; Nordamerika mit sequentieller Verbesserung; Asien-Pazifik wuchs solide ausserhalb China (verlangsamter Patientenzulauf vor Einführung von VBP 2.0); Lateinamerika setzte Wachstumskurs fort
Transformation......
Themefolio
Profiler
Peergroup
© EQS Newswire
29.10.2025
ISIN: CH1175448666
Straumann Holding AG
STMN
LISTED
SIX
Straumann Group delivers strong organic growth and confirms full-year outlook
News Preview
Third-quarter revenue amounted to CHF 602.2 million, a 8.3% organic revenue growth
EMEA remained the key growth driver, NAM showed sequential improvement, APAC solid outside China while patient flow slowdown ahead of VBP 2.0, and LATAM continued its growth path
Orthodontics business transformation through a strategic partnership with Smartee and......
Themefolio
Profiler
Peergroup
© EQS Newswire
29.10.2025
ISIN: CH1251125998
Relief Therapeutics Holding SA
RLF
LISTED
SIX
Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032
News Preview
Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032
RLF-OD032 demonstrated bioequivalence to KUVAN® Powder
Study results support planned 505(b)(2) NDA submission in early 2026
GENEVA (OCT. 29, 2025) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief, or the Company), a biopharmaceuti......
Themefolio
Profiler
Peergroup
© EQS Newswire
29.10.2025
ISIN: CH1175448666
Straumann Holding AG
STMN
LISTED
SIX
Straumann Group transformiert ihr Kieferorthopädie-Geschäft durch neue strategische Partnerschaften und einen geschärften Marktfokus
News Preview
Straumann Holding AG
/ Schlagwort(e): Kooperation
Straumann Group transformiert ihr Kieferorthopädie-Geschäft durch neue strategische Partnerschaften und einen geschärften Marktfokus
29.10.2025 / 06:55 CET/CEST
Transformation des Kieferorthopädie-Geschäfts der Straumann Group durch beschleunigte Innovation, Fokus auf ......
Themefolio
Profiler
Peergroup
© EQS Newswire
29.10.2025
ISIN: CH1175448666
Straumann Holding AG
STMN
LISTED
SIX
Straumann Group transforms its orthodontics business through new strategic partnerships and a sharpened market approach
News Preview
Straumann Holding AG
/ Key word(s): Alliance
Straumann Group transforms its orthodontics business through new strategic partnerships and a sharpened market approach
29.10.2025 / 06:55 CET/CEST
Transforming the Straumann Group’s orthodontics business through accelerated innovation, key market focus and operational e......
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
LEVI & KORSINSKY ISSUES CORRECTION: Securities Fraud Class Action Against Savara Inc.
News Preview
NEW YORK, Oct. 29, 2025 /PRNewswire/ -- A securities fraud class action lawsuit against Savara Inc. (NASDAQ: SVRA) is pending. The lawsuit was filed by Pomerantz LLP. A previous press release stated incorrectly that Levi & Korsinsky filed the case. This press release makes that correction. There are no other...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: CH0029850754
Addex Therapeutics Ltd
ADXN
LISTED
SIX
Addex Increases Issued Share Capital to Create Treasury Shares
News Preview
Ad Hoc Announcement Pursuant to Art. 53 LR...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: CH0012032048
Roche Holding AG
ROG
LISTED
SIX
Roche receives CE mark for novel automated high-throughput Elecsys Dengue Ag test to diagnose dengue
News Preview
Basel, 29 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received CE mark for its Elecsys® Dengue Ag test – a high-throughput, fully automated immunoassay to be used as an aid in the diagnosis of an acute dengue virus infection. This milestone promises to set a new standard for efficiency and reliability in tackling t...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.10.2025
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec SE to Announce Results for The First Nine Months 2025 on 05 November 2025
News Preview
HAMBURG, DE / ACCESS Newswire / October 29, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ:EVO) will announce its interim statement for the first nine months 2025 on Wednesday, 05 November 2025.The Company is going to hold a conference call to discuss the results as well as provi...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.10.2025
ISIN: CH1251125998
Relief Therapeutics Holding SA
RLF
LISTED
SIX
Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032
News Preview
RLF-OD032 demonstrated bioequivalence to KUVAN® PowderStudy results support planned 505(b)(2) NDA submission in early 2026 GENEVA, SWITZERLAND / ACCESS Newswire / October 29, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatme...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US05380C1027
AVITA Medical Inc
RCEL
LISTED
NASDAQ
Rosen Law Firm Encourages AVITA Medical, Inc. Investors to Inquire About Securities Class Action Investigation – RCEL
News Preview
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of AVITA Medical, Inc. (NASDAQ: RCEL) resulting from allegations that AVITA Medical may have issued materially misleading business information to the investing public.
So What: If you purchased AVITA Medical...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: IE00BTN1Y115
Medtronic PLC
MDT
LISTED
NYSE
U.S. Centers for Medicare & Medicaid Services finalizes National Coverage Determination for the Medtronic Symplicity Spyral™ renal denervation (RDN) system
News Preview
Symplicity blood pressure procedure is now covered for qualifying Medicare patients
GALWAY, Ireland, Oct. 28, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the Centers for Medicare & Medicaid Services (CMS) has released the final...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US6402683063
Nektar Therapeutics
NKTR
LISTED
NASDAQ
Nektar to Announce Financial Results for the Third Quarter on Thursday, November 6, 2025, After Close of U.S.-Based Financial Markets
News Preview
SAN FRANCISCO, Oct. 28, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter on Thursday, November 6, 2025, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference call to review the r...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US03675P1021
Anteris Technologies Global Corp.
AVR
LISTED
NASDAQ
Anteris DurAVR® THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with no Valve Related Mortality at One Year
News Preview
Anteris DurAVR THV demonstrates favorable hemodynamics in small annuli patients with no valve related mortality at one year - TCT oral presentation...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Semler Scientific® to Release Third Quarter 2025 Financial Results
News Preview
CAMPBELL, Calif., Oct. 28, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and a leader in medical devices and software to combat chronic diseases, today announced that due to its pending transaction with Strive, In...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: NL0015002CX3
Qiagen NV
QGEN
LISTED
NYSE
QIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership in Automated Sample Processing
News Preview
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the 4,000th placement of its QIAcube Connect instrument, a significant milestone in driving automation adoption for sample processing across life science and diagnostic labs.
This accomplishment is underscored by the nearly 13,000 cumulative placements of QIAcube platforms global...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
Molina Healthcare, Inc. (MOH) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
BENSALEM, Pa., Oct. 28, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Molina Healthcare, Inc. ("Molina" or the "Company") (NYSE: MOH).
IF YOU ARE...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
DCXM ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of DexCom, Inc. Investors
News Preview
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ:DXCM) securities during the period of July 26, 2024 through September 17, 2025, inclusive (“the Class Period”).
If you suffered a loss on your DexCom investments, you have u...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 28, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to aTyr Pharma Inc. ("aTyr" or the "Company") (NASDAQ: ATYR) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US04280A1007
Arrowhead Pharmaceuticals Inc
ARWR
LISTED
NASDAQ
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
News Preview
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that as an inducement to entering into employment with the Company, on October 24, 2025, the Company’s Board of Directors approved “inducement” grants to 84 new employees under Rule 5635(c)(4) of the NASDAQ Listing Rules. The grants entitle employees, in aggregate, to receive up to 127...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US45685K1025
InfuSystem Holdings Inc
INFU
LISTED
XASE
InfuSystem to Report Third Quarter 2025 Financial Results on November 4, 2025
News Preview
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue third quarter 2025 financial results on Tuesday, November 4, 2025, before the market open...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: VGG205281089
Charming Medical Ltd
MCTA
LISTED
NASDAQ
Charming Medical Limited Announces Full Exercise of Representative's Over-allotment Option
News Preview
HONG KONG, Oct. 28, 2025 /PRNewswire/ -- Charming Medical Limited (Nasdaq: MCTA) (the "Company"), a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products, today announced, in connection with its previously announced initial public offering (the "Offering") of 1,600,000 Cla...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US29332G1022
Enhabit Inc
EHAB
LISTED
NYSE
Enhabit Announces Participation in UBS Global Healthcare Conference 2025
News Preview
Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced its participation in the UBS Global Healthcare Conference 2025.
Enhabit’s President and CEO Barb Jacobsmeyer and Chief Financial Officer Ryan Solomon will participate in a fireside chat on Tuesday, Nov. 11 at 11:30 a.m. CT. The fireside chat will be...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: FR0004163111
Genfit SA
GNFT
LISTED
EURONEXT
GENFIT Announces Advances Across its ACLF Pipeline at AASLD The Liver Meeting® 2025
News Preview
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), October 28, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced its participation at the upcoming American Association for the Study of Liver D...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: IE00B4Q5ZN47
Jazz Pharmaceuticals PLC
JAZZ
LISTED
NASDAQ
Jazz Pharmaceuticals Appoints Ted W. Love, M.D., to its Board of Directors
News Preview
Dr. Love, a biopharmaceutical industry veteran, brings extensive executive leadership and board experience with proven success in creating shareholder value
DUBLIN, Oct. 28, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Ted W....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US2307701092
Cumberland Pharmaceuticals, Inc.
CPIX
LISTED
NASDAQ
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q3 2025 FINANCIAL RESULTS & COMPANY UPDATE
News Preview
NASHVILLE, Tenn., Oct. 28, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its third quarter 2025 financial results and provide a Company update after the market closes on Tuesday, Nov. 4, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US75340L1044
Rapid Micro Biosystems Inc
RPID
LISTED
NASDAQ
Rapid Micro Biosystems to Announce Third Quarter 2025 Financial Results on November 7, 2025
News Preview
LEXINGTON, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release third quarter 2025 financial results p...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
